Now showing items 1-1 of 1

    • Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database . 

      Møller, P; Seppälä, TT; Bernstein, I; Holinski-Feder, E; Sala, P; Gareth Evans, D; Lindblom, A; Macrae, F; Blanco, I; Sijmons, RH; Jeffries, J; Vasen, HFA; Burn, J; Nakken, S; Hovig, E; Rødland, EA; Tharmaratnam, K; de Vos Tot, Nederveen Cappel, WH; Hill, J; et al [Incl Mecklin, J-P] in collaboration with The Mallorca Group (BMJ, 2018)
      Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now survive both their first and subsequent cancers, resulting in a growing number of older patients with LS for whom limited information exists ...
      Tieteelliset aikakauslehtiartikkelit